Does posaconazole prevent invasive fungal infections in patients with neutropenia?

Article metrics

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Groll AH et al. (2001) Prevention of fungal infections in children and adolescents with cancer [German]. Klin Padiatr 213 (Suppl 1): SA50–SA68

  2. 2

    Marr KA et al. (2004) Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Blood 103: 1527–1533

  3. 3

    Slavin MA et al. (1995) Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double-blind study. J Infect Dis 171: 1545–1552

  4. 4

    De Pauw BE and Donnelly JP (2007) Prophylaxis and aspergillosis—has the principle been proven? N Engl J Med 356: 409–411

  5. 5

    Ullmann AJ et al. (2007) Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 356: 335–347

Download references

Acknowledgements

The synopsis was written by Helen Jaques, Editorial Assistant, Nature Clinical Practice.

Author information

Ethics declarations

Competing interests

The author has declared associations with the following companies: research support from Gilead Sciences, Merck Sharpe & Dohme and Pfizer; and consultation and speaker fees from Astellas Pharma, Gilead Sciences, Merck Sharpe & Dohme, Pfizer, Schering-Plough and Unichem

Rights and permissions

Reprints and Permissions

About this article